TetraLogic Pharmaceuticals Corp (TLOG)
0.00
USD |
OTCM |
Apr 18, 16:00
TetraLogic Pharmaceuticals Cash from Operations (TTM): -23.88M for Sept. 30, 2016
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2016 | -23.88M |
| June 30, 2016 | -28.76M |
| March 31, 2016 | -33.69M |
| December 31, 2015 | -34.89M |
| September 30, 2015 | -37.01M |
| June 30, 2015 | -37.17M |
| Date | Value |
|---|---|
| March 31, 2015 | -33.57M |
| December 31, 2014 | -32.37M |
| September 30, 2014 | -23.73M |
| June 30, 2014 | -19.44M |
| March 31, 2014 | -15.07M |
| December 31, 2013 | -12.77M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Ampio Pharmaceuticals Inc | -8.564M |